Author:
Pouna Paul,Bonoron-Ad�le Simone,Gouverneur G�rard,Tariosse Liliane,Besse Pierre,Robert Jacques
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference32 articles.
1. Unverferth DV, Magorien RD, Leier CV, Balcerzak SP (1982) Doxorubicin cardiotoxicity. Cancer Treat Rev 9: 149
2. Casazza AM (1986) Preclinical selection of new anthracyclines. Cancer Treat Rep 70: 43
3. Cummings J, Anderson L, Willmott N, Smyth JF (1991) The molecular pharmacology of doxorubicin in vivo. Eur J Cancer 27: 532
4. Ganzina F (1983) 4?-Epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical data. Cancer Treat Rev 10: 1
5. Maehara Y, Sakaguchi Y, Kusumoto T, Kusumoto H, Sugimachi K (1989) 4?-O-Tetrahydropyranyladriamycin has greater antineoplastic activity than doxorubicin in various human tumours in vitro. Anticancer Res 9: 387
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献